A new gene therapy track to fight cancer
September 18, 2018
A Suicide Gene Therapy Combining the Improvement of Cyclophosphamide Tumor Cytotoxicity and the
The Integrated Cancer Research Sites (SIRIC)
In recent years, cancers have become the leading cause of death ahead of cardiovascular diseases. In this health context, France has promoted a cancer control policy since the 2000s, which resulted in three presidential plans launched successively in 2003, 2009 and 2014. The first Cancer Plan created the l’Institut National du Cancer (INCa), National Cancer Institute and thus enabled to assert the performance and international visibility of French Oncology particularly thanks to the powerful mobilization of medical and scientific communities. The first 2 Plans have largely contributed to the mobilization and structuring of the scientific and medical community to conduct research projects of excellence (fundamental, clinical, epidemiological and social sciences and humanities) and to develop the translational and multidisciplinary approach.
In 2010 and 2011, with the dual objective of developing and conducting integrated research programs, but also ensuring the dissemination of research results, INCa launched calls for projects for the accreditation of Site de Recherche Intégrée sur le Cancer (SIRIC). Since 2011, eight SIRIC, including CARPEM (CAncer Research for PErsonalized Medicine), have been labeled. They must offer cancer research new operating conditions in order to optimize and accelerate the production of new knowledge and to promote their dissemination and application in the management of cancer.
The importance and priority of the SIRIC program are supported in the Cancer Plan 3. In 2017, INCa launched a new SIRIC labeling campaign. This one maintains the objectives fixed previously and which demonstrated their relevance, namely:
- carry out a triple mission of integration, structuring and valorization to develop a research program of excellence transposable for the benefit of the general population and people affected by cancer;
- reinforce the level of creativity and international competitiveness of the research carried out by their teams on the prevention, diagnosis and treatment of cancers.
The SIRICs in France
INCa’s call for applications in 2017 has labeled 8 SIRICs (Integrated Cancer Research Sites).
These are the sites of:
- SIRIC of Lyon – LYRICAN
- SIRIC of Gustave Roussy Institute– SOCRATE2.0
- SIRIC of Curie Institute
- SIRIC of Bordeaux – BRIO
- SIRIC of Georges Pompidou and Cochin hospitals– CARPEM
- SIRIC of Pitié-Salpêtrière hospital– CURAMUS
- SIRIC of Nantes – ILIAD
RELEASES
Xème Symposium Jecco
September 14, 2018
Le CARPEM soutient le Xème Symposium JeCCo “Une nouvelle approche du Cancer” qui
Presentation of CARPEM – Pr Pierre Laurent-Puig
September 14, 2018
Professor Pierre Laurent-Puig, director of CARPEM (Cancer Research for Personalized Medicine), presents the
INFORMATION
Calls for projects
2018 calls for projects are open !
Trainings
2018 trainings
Job offers
Check our job offers
Contacts
For more information, please contact
Contact us
Centre Universitaire des Saints-Pères Etage 4 – Pièce 446B 45 rue des Saints-Pères -75006 Paris
Carina Binet : Secrétaire Général du CARPEM
Tél. : 01 76 53 43 85 – carina.binet@carpem.fr
Aurore Hattabi, PhD : Coordinatrice Scientifique du CARPEM
Tél : 01 76 53 43 85 – aurore.hattabi@carpem.fr